MMAE-atezolizumab also displayed anti-tumor activity in vivo, in a mouse model represented by PD-1-humanized mice and a PD-L1-genetically engineered MC38 mouse colon cancer cell line. This evidence concerns the gene CD274 and malignant colon neoplasm.